| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |